Heavy Menstrual Bleeding
Pipeline by Development Stage
On Market (1)
Approved therapies currently available
Competitive Landscape
10 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (9)
Total enrollment: 1,412 patients across 9 trials
Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Delivering tAN to Reduce HMB: The LUNA Study
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Transcutaneous Auricular Neurostimulation as a Treatment for Women With Heavy Menstrual Bleeding: A Dose-finding Trial
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
Effectiveness of Truclear on Patient Quality of Life
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.